2022 American Transplant Congress
Revision Ureteroneocystostomy in Pediatric Renal Transplant Patients for Symptomatic Vesicoureteral Reflux and Its Effect on Recurrent Hospitalizations
1Naval Medical Center San Diego, San Diego, CA, 2UCSD Rady Children's Hospital, San Diego, CA
*Purpose: To evaluate the effect of revision ureteroneocystostomy on pediatric renal transplant patients with symptomatic vesicoureteral reflux (VUR) in reducing hospitalizations and recurrent urinary tract…2022 American Transplant Congress
Prediction of ESRD Risk in Living Kidney Donors Through Thirty Years Post-Donation
1Johns Hopkins, Baltimore, MD, 2Scientific Regristry of Transplant Recipients, Minneapolis, MN
*Purpose: Living kidney donors face increased risk of ESRD, although absolute risk remains low through 20 years postdonation. Informed consent for kidney donation depends on…2022 American Transplant Congress
Outcomes of Post-Operative Plasmapheresis in African American Kidney Transplant Recipients with High Panel Reactive Antibodies – A Single Center Experience
University of Illinois at Chicago, Chicago, IL
*Purpose: African American (AA) kidney transplant (KTx) candidates are disadvantaged given increased immunologic risk and longer waitlist time. The purpose of this study was to…2022 American Transplant Congress
The Price of Cold Ischemia Time
1JHU, Baltimore, MD, 2Surgery, University of Maryland, Baltimore, MD
*Purpose: Recent allocation policy changes for deceased-donor kidney transplantation (DDKT) have favored geographic equity over local allocation. Increasing travel distance has the potential to increase…2022 American Transplant Congress
Chronic Active Antibody Mediated Rejection: 3 Month Response Rates to Treatment and Predictors of Graft Survival
University of Wisconsin, Madison, WI
*Purpose: There is limited information on effectiveness of treatment and predictors of graft survival following chronic active antibody mediated rejection (cABMR) in kidney transplant recipients…2022 American Transplant Congress
Performance of Donor Derived Cell Free DNA (dd-cfDNA) in Diagnosing Subclinical and Clinical Acute Rejection in Kidney Transplant Recipients
*Purpose: The aim of this study was to examine the performance of Viracor TRAC donor derived cell free DNA (dd-cfDNA) in for-cause biopsies as well…2022 American Transplant Congress
A Decennial Summary of the OPTN Kidney Paired Donation Pilot Program
*Purpose: The OPTN Kidney Paired Donation Pilot Program (KPDPP) is a national KPD system that has served the kidney transplant community for over 10 years.…2022 American Transplant Congress
Outcome of Solid Organ Transplantation in Candidates with Intellectual Disability: A Systematic Review
Erasmus MC, Rotterdam, Netherlands
*Purpose: The allocation of organs comes with an ethical discussion in patients with intellectual disability. Historically, intellectual disability was considered a relative contra-indication for organ…2022 American Transplant Congress
Single Center Assessment of Completing Kidney Evaluations: Race and Ethnicity Were Not Predictors for Preemptive Kidney Transplant Patients
Houston Methodist, Houston, TX
*Purpose: This study examines the differential progress from beginning the transplant evaluation process to its completion and subsequent presentation to the Candidate Selection Committee (CSC)…2022 American Transplant Congress
Donor Black Race Modifies the Association Between Increasing Donor Age and Graft Failure Following Living Kidney Transplantation
Tulane University, New Orleans, LA
*Purpose: Transplantation utilizing Black living donor kidneys is associated with poorer outcomes.A possible explanation is genetic(APOL1). Kidneys from healthy older Black donors are considered lower…
- « Previous Page
- 1
- …
- 9
- 10
- 11
- 12
- 13
- …
- 101
- Next Page »